Chatbot Facilitated Education on Child and Adolescent Abuse

NCT06167031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2025-08-17

Study results available
· View outcomes & findings →

Summary

The study aims to evaluate the effectiveness of chatbot-facilitated education (CFE) in assisting nursing personnel to prevent child and adolescent abuse and neglect (CAN). The main questions it aims to answer are:

1. Does applying CFE enhance nurses' intention to report CAN?
2. Does applying CFE improve nurses' attitudes toward reporting CAN?
3. Does applying CFE increase nurses' knowledge of CAN?

Researchers will compare CFE to lecture-based teaching to verify if CFE can improve the nurses' competency of CAN.

Participants will:

1. Attend a CAN course for about 1.5 hours. The experimental group will use CFE, and the control group will only receive lecture-based teaching.
2. Have the CAN course, comprised of two main subjects: "CAN" and "Nurses' Roles and Functions in CAN".
3. Receive the learning effect assessment at three different time points: before the course, one week after, and four weeks after.

Conditions

  • Child Abuse

Interventions

OTHER

chatbot facilitated teaching

The experimental group will use "chatbot" to facilitate teaching.

OTHER

lecture-based teaching

The control group only receives lecture-based teaching.

Sponsors & Collaborators

  • Tzu Chi University

    lead OTHER

Principal Investigators

  • Mei-Lin Hsieh · Tzu Chi University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-01-17
Completion
2024-04-08

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06167031 on ClinicalTrials.gov